Results 11 to 20 of about 1,007,107 (382)

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

open access: yesJournal of Thrombosis and Haemostasis, 2020
In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus pneumonia (NCP) cases were a concern.
N. Tang   +3 more
semanticscholar   +2 more sources

Asthma and coagulation [PDF]

open access: yesNew England Journal of Medicine, 2013
Asthma is characterized by chronic inflammation of the airways, contraction of smooth muscle, overproduction of mucus, and remodeling of the airway wall. In many forms of asthma, there is an accumulation of eosinophils, which predicts a good response to inhaled glucocorticoids.
Hammad, Hamida, Lambrecht, Bart
core   +3 more sources

The Crossroads of the Coagulation System and the Immune System: Interactions and Connections

open access: yesInternational Journal of Molecular Sciences, 2023
The coagulation and immune systems, two vital systems in the human body, share intimate connections that fundamentally determine patient health. These systems work together through several common regulatory pathways, including the Tissue Factor (TF ...
Grzegorz Wilhelm   +6 more
semanticscholar   +1 more source

Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Introduction In 2017, all people with severe hemophilia B in Ireland switched to recombinant factor IX Fc fusion protein concentrate (rFIXFc) prophylaxis.
Mairead O’Donovan   +11 more
doaj   +1 more source

Utility of ACMG classification to support interpretation of molecular genetic test results in patients with factor VII deficiency

open access: yesFrontiers in Medicine, 2023
BackgroundThe American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) have introduced an internationally shared framework for variant classification in genetic disorders.
Rosa Sonja Alesci   +4 more
doaj   +1 more source

Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin

open access: yesScientific Reports, 2023
Cyclosporine-A (CsA) is used to prevent acute graft-versus-host disease (aGvHD). European Society for Blood and Marrow transplantation (EBMT) recommends a CsA target serum concentration of 200–300 µg/L during the first month after allogeneic ...
Mikael Lisak   +9 more
doaj   +1 more source

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background DOAC Filter (DF) is a new device to overcome interference in lupus anticoagulant (LAC) testing by direct oral anticoagulants (DOACs). Objectives We evaluated DOAC removal from plasma and elimination of DOAC interference in LAC testing by DF ...
Eleni A. Linskens   +2 more
doaj   +1 more source

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

open access: yesClinical Chemistry and Laboratory Medicine, 2020
Background As the number of patients increases, there is a growing understanding of the form of pneumonia sustained by the 2019 novel coronavirus (SARS-CoV-2), which has caused an outbreak in China.
Huan Han   +7 more
semanticscholar   +1 more source

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

open access: yesBlood, 2020
Patients with coronavirus disease 2019 (COVID-19) have elevated D-dimer levels. Early reports describe high venous thromboembolism (VTE) and disseminated intravascular coagulation (DIC) rates, but data are limited.
Hanny Al‐Samkari   +12 more
semanticscholar   +1 more source

Heparin-induced thrombocytopenia and COVID-19

open access: yesHematology Reports, 2021
Heparin-induced thrombocytopenia (HIT) has not been included as a possible cause of thrombocytopenia in Coronavirus Disease 2019 (COVID-19) patients. We report a case of HIT in a patient with COVID-19 treated with heparin.
Michelangelo Sartori, Benilde Cosmi
doaj   +1 more source

Home - About - Disclaimer - Privacy